A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Paratus Clinical Research Western Sydney, Blacktown

Paratus Clinical Kanwal, Kanwal

Emeritus Research, Camberwell

Nucleus Network Brisbane Clinic - Centre For Clinical Studies, Herston

Paratus Clinical Research Brisbane, Albion

University of the Sunshine Coast, South Brisbane

Trial Management Associates, Wilmington

Lucas Research, Inc. (Diabetes & Endocrinology Consultants PC), Morehead City

Trial Management Associates, Myrtle Beach

Velocity Clinical Research, Anderson

Cenexel IRA (iResearch Atlanta), Decatur

Atlanta Center for Medical Research - Family Medicine, Atlanta

Centricity Research, Columbus

Accel Research Sites, DeLand

Research Centers of America (cenexel), Hollywood

Accel Research Sites, St. Petersburg

DM Clinical Research, Southfield

Optimal Research, Peoria

DM Clinical Research, Houston

DM Clinical Research, Sugar Land

AusTrials Taringa, Taringa

Newcastle University - Institute of Cellular Medicine (ICM), Newcastle

Nottingham University Hospitals NHS Trust - Queen's Medical Centre (QMC) Campus, Nottingham

University of Oxford, Oxford

Bristol Royal Hospital for Children, Bristol

Royal Devon & Exeter Hospital, Exeter

Chelsea and Westminster Hospital, London

St George's Healthcare NHS Trust - University of London - Th, London

National Hospital for Neurology and Neurosurgery, London

Southampton General Hospital, Southampton